Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07395258 | A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) | suspended | Phase 1 | 60 | Boehringer IngelheimINDUSTRY | 1 | Jun 4, 2026 | clinicaltrials |
| NCT06806228 | Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) | suspended | Phase 1 | 10 | Petrov, AndreyOTHER | 3 | Jun 3, 2026 |
| clinicaltrials |
| NCT01083966 | Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma | suspended | Phase 1 | 30 | Northwell HealthOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT01386710 | Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma | suspended | Phase 1 / Phase 2 | 54 | Northwell HealthOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT04222309 | Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) | suspended | Phase 1 | 10 | Northwell HealthOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT04981834 | Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer | suspended | N/A | 196 | University of Southern CaliforniaOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT06405061 | Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma | suspended | Phase 2 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT03275298 | Evolution of the Therapeutic Care in Ovarian Cancer From 2011(ESME OC) | suspended | — | 13,331 | UNICANCEROTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT06391099 | Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer | suspended | N/A | 60 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT04381806 | Phase I Study in Advanced Malignancies With 5-ALA | suspended | Phase 1 | 130 | Fox Chase Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT04975217 | Fecal Microbial Transplants for the Treatment of Pancreatic Cancer | suspended | Early Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT05198479 | Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in(SG-AAA-II-01) | suspended | Phase 2 | 25 | National Cancer Centre, SingaporeOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT02130492 | A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG) | suspended | Phase 1 / Phase 2 | 30 | Weill Medical College of Cornell UniversityOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT03568292 | Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures | suspended | N/A | 60 | University of Southern CaliforniaOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT04955808 | Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery | suspended | — | 2,400 | National Cancer Institute (NCI)NIH | 1 | May 13, 2026 | clinicaltrials |
| NCT04025515 | Molecular Profiling Project | suspended | — | 500 | National Cancer Centre, SingaporeOTHER | 6 | May 12, 2026 | clinicaltrials |
| NCT02354547 | A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors | suspended | Phase 1 | 18 | SynerGene Therapeutics, Inc.INDUSTRY | 1 | May 8, 2026 | clinicaltrials |
| NCT05200442 | A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer | suspended | Phase 1 / Phase 2 | 53 | University of ChicagoOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT04541381 | The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care | suspended | N/A | 860 | University of ChicagoOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT06653010 | Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer(Wondercel-UWD1) | suspended | Early Phase 1 | 30 | Wondercel Biotech (ShenZhen)INDUSTRY | 1 | May 7, 2026 | clinicaltrials |
| NCT06653023 | Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer(Wondercel-UWD3) | suspended | Early Phase 1 | 60 | Wondercel Biotech (ShenZhen)INDUSTRY | 1 | May 7, 2026 | clinicaltrials |
| NCT06662227 | Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors | suspended | Early Phase 1 | 30 | Wondercel Biotech (ShenZhen)INDUSTRY | 1 | May 7, 2026 | clinicaltrials |
| NCT06663046 | Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma | suspended | Early Phase 1 | 30 | Wondercel Biotech (ShenZhen)INDUSTRY | 1 | May 7, 2026 | clinicaltrials |
| NCT06675513 | Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer | suspended | Early Phase 1 | 30 | Wondercel Biotech (ShenZhen)INDUSTRY | 1 | May 7, 2026 | clinicaltrials |
| NCT05206942 | Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy | suspended | N/A | 30 | Stanford UniversityOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT06653192 | EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial) | suspended | N/A | 120 | Hospital Universitari de BellvitgeOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT03838419 | Intraoperative Electron Radiotherapy for Low-risk Early Breast Cancer(COSMOPOLITAN) | suspended | N/A | 101 | University Hospital HeidelbergOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT04929015 | Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study) | suspended | N/A | 30 | Rutgers, The State University of New JerseyOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT05337735 | A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers | suspended | Phase 2 | 140 | M.D. Anderson Cancer CenterOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT05362032 | Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate | suspended | N/A | 45 | OHSU Knight Cancer InstituteOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06379581 | Skin Cancer Diagnostics Using Photoacoustic Imaging | suspended | — | 200 | Region SkaneOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07173374 | Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study(SCART-P) | suspended | Phase 1 | 24 | Shandong Cancer Hospital and InstituteOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT04336202 | Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy(Whistle) | suspended | N/A | 45 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT05513859 | Investigational Imaging Technique During Brain Surgery | suspended | N/A | 24 | Emory UniversityOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT05887882 | Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors(PNOC028) | suspended | Phase 1 | 24 | Sabine Mueller, MD, PhDOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT04266730 | Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab(PANDA-VAC) | suspended | Phase 1 | 6 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT03575611 | Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma | suspended | Phase 2 | 123 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT05091632 | Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care Unit | suspended | — | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT05866679 | Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging | suspended | Phase 1 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT00280189 | Study of Outcomes of Radiofrequency Ablation of Lung Tumors | suspended | — | 72 | University of PittsburghOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT07140965 | The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment | suspended | — | 175 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT05210933 | Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry(SMART) | suspended | — | 750 | University of AlbertaOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT04908111 | A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 | suspended | Phase 1 / Phase 2 | 15 | Cancer Research UKOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT05547347 | Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer | suspended | — | 15 | Mayo ClinicOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT02333162 | Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant | suspended | Phase 1 | 30 | University of ChicagoOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT02366819 | Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer | suspended | Phase 4 | 36 | University of ChicagoOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT06171152 | Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues | suspended | Early Phase 1 | 30 | University of ChicagoOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07300319 | The Effects of Chiropractic on Cancer-related Fatigue(CAN) | suspended | N/A | 40 | Life UniversityOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT04278768 | Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) | suspended | Phase 1 / Phase 2 | 366 | Curis, Inc.INDUSTRY | 8 | Mar 19, 2026 | clinicaltrials |
| NCT04890093 | Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors | suspended | Phase 1 / Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Mar 16, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Jun 4, 2026source: clinicaltrials